Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Analytikerkommentar

Aiforia raised 8 MEUR in an expected directed issue

Aiforia Technologies

Translation: Original published in Finnish on 5/28/2025 at 8:10 am EEST.

The issue was fully expected, as we believe the company’s implementation of its growth strategy requires additional funding to be collected this year. The terms (EUR 3.2 per share, gross proceeds of some 8 MEUR) were quite well in line with our expectations. With the issue, the company can continue implementing its growth strategy that has progressed well without material short-term financing risks.

8 MEUR collected in the issue before costs

In the directed share issue announced yesterday, Aiforia will issue roughly 2.5 million new shares. The subscription price of the shares in the issue was EUR 3.20 per share, which corresponds to a discount of approximately 8% on yesterday's (May 26) closing price of EUR 3.47 per share and approximately 10.6% lower price compared to the three-month volume-weighted average share price (EUR 3.58). The issue was carried out in an accelerated bookbuilding process based on bids. The issue was aimed at domestic and international institutional investors and other professional investors. The new shares account for approximately 8.0% of all Aiforia shares after the issue, so the dilution is quite moderate.

The successful issue came as no surprise, as the implementation of Aiforia’s growth strategy has progressed well and we thus believe the company was in a good position in the financing negotiations. Aiforia raised gross proceeds of 8 MEUR in the share issue, which, after typical costs of around 5-10%, would correspond to net assets of 7.2-7.6 MEUR. In a well-organized directed issue, the cost level should definitely remain at the lower end of the range. In our previous valuation (4/23/2025), we had included a 10 MEUR share issue in 2025 (and another one in 2026), at a price of EUR 3.10 per share, excluding costs. Considering the typical costs of approximately 5-10% for the directed issue carried out at EUR 3.5 per share, the issue was largely as expected.

Before the issue, we estimated that Aiforia will raise a total of some 20 MEUR in additional funding to enable maintaining growth investment and achieving cash-flow neutrality, so the directed issue covers just under half of this. With our forecasts, the company's financing need would be covered with the support of the offering until 2026, and the company's cash flow after investments would turn positive during 2028. 

We feel the elimination of short-term financial uncertainties with expected terms is in principle positive for the company, even though a share issue carried out slightly below yesterday’s closing price may also bring short-term downward pressure to the share and room for play. 

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Læs mere på virksomhedsside

Key Estimate Figures23.04

202425e26e
Omsætning2,94,77,6
vækst-%18,9 %65,7 %60,0 %
EBIT (adj.)-12,2-11,9-12,0
EBIT-% (adj.)-427,8 %-252,9 %-158,1 %
EPS (adj.)-0,41-0,37-0,38
Udbytte0,000,000,00
Udbytte %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forumopdateringer

Også dette begrænser emissioner i januar. Personer i ledende stillinger hos udstederen er omfattet af et 30-dages lukket vindue før offentligg...
for 12 timer siden
af Zen65
1
Bliver den ejerliste opdateret inden handelens start med disse nye aktier den 15. eller ser man først i starten af januar, som det sædvanligvis...
for 13 timer siden
af Salvelinus
0
Nogen talte om, at det ville have været bedre at vente til januar med emissionen, måske for kursens skyld, men har nogen overhovedet nogensinde...
for 15 timer siden
af Zen65
0
Aiforia Technologies Oyj – Ledelsens transaktioner – Tuomas Tenkanen Aiforia Technologies Oyj TRANSAKTIONER UDFØRT AF PERSONER MED LEDELSESANSVAR...
for 16 timer siden
af Uuno
6
Det lader til, at emissionen ikke solgte særlig godt, da Tenkanen fik flere aktier end oprindeligt forpligtet: \u003e TJT Technologies Oy, et...
for 16 timer siden
4
Dette opfylder vel i sig selv kendetegnene for et kriselignende selskab, når der tales om en rettet emission. Ellers skulle man næste år lukke...
i går
af Zen65
0
Du virker ophidset ud fra tonen i din tekst, så nu ville det være godt at trække vejret ind og ud og falde lidt til ro, så den konstruktive ...
i går
af Pohjolan Eka
27
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.